secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-02-07T23:59:59+00:00
Accession:  0000950170-22-000832
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences appoints Stan Jacot as CEO; grants inducement option for 316K shares
--------------------------------------------------------------------------------

- Stan Jacot named President and CEO effective Feb 2, 2022; previous president of Jane's Dough Foods (6-year tenure with double-digit CAGR).
- Annual base salary $350,000, target bonus 50% of base; inducement stock option for 316,108 shares at $0.91 (vests over four years).
- Kevin Comcowich steps down as interim CEO but remains Chairman of the Board.
- Severance agreement provides 9 months base salary continuation (non-CIC) or 12 months with full equity vesting acceleration after change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022000832/0000950170-22-000832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022000832/rkda-20220202.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-000832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer